{"product_id":"anti-hepatitis-e-virus-hev-porf2-p-domain-neutralizing-antibody-saa2240-bha21405139","title":"Anti-Hepatitis E virus\/HEV pORF2 P domain Neutralizing Antibody (SAA2240)","description":"\u003cp\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003cbr\u003eAntibody against Hepatitis E virus\/HEV pORF2 P domain Neutralizing (pORF2 P domain) for research detection of protein expression and localization.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eTarget biology\u003c\/strong\u003e\u003cbr\u003eHEPATITIS is a molecular target commonly interrogated by antibody-based methods to measure protein expression, localization and regulation across biological systems. Antibodies against HEPATITIS support studies ranging from baseline expression profiling to stimulus- or disease-associated changes in abundance and subcellular distribution. For pathway-level interpretation, pair HEPATITIS detection with appropriate controls and complementary readouts (e.g., genetic perturbation or orthogonal assays).\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eExpected localization\u003c\/strong\u003e\u003cbr\u003eSubcellular localization is target- and context-dependent; use cell-type appropriate controls and, where possible, genetic KO\/KD as specificity controls.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch context\u003c\/strong\u003e\u003cbr\u003eThis target is frequently studied in the context of \u003cem\u003eInfectious Disease\u003c\/em\u003e research. Application suitability (e.g., Neutralization, ELISA, SPR) is indicated in the specifications; conditions should be optimized by titration.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eRecommended experimental notes\u003c\/strong\u003e\u003c\/p\u003e\u003cul\u003e\u003cli\u003eFor ELISA, ensure capture\/detection antibody compatibility and run a standard curve; verify sample matrix effects with spike-and-recovery and dilution linearity.\u003c\/li\u003e\u003c\/ul\u003e\u003cp\u003e\u003cstrong\u003eControls \u0026amp; interpretation\u003c\/strong\u003e\u003cbr\u003eWhere possible, confirm specificity using genetic perturbation (KO\/KD\/CRISPR), peptide competition (if applicable), or an orthogonal readout. Include a negative control sample expected to express low\/none of Hepatitis E virus\/HEV pORF2 P domain Neutralizing, and a positive control sample known to express Hepatitis E virus\/HEV pORF2 P domain Neutralizing.\u003c\/p\u003e\u003cp\u003e\u003cem\u003eFor research use only. Not for diagnostic procedures.\u003c\/em\u003e\u003c\/p\u003e","brand":"Biohippo Inc","offers":[{"title":"50 ug","offer_id":53036917391725,"sku":"VK620043-50UG","price":191.0,"currency_code":"USD","in_stock":true},{"title":"100 ug","offer_id":53037507838317,"sku":"VK620043-100UG","price":370.0,"currency_code":"USD","in_stock":true},{"title":"1 mg","offer_id":53037507871085,"sku":"VK620043-1MG","price":1858.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/VK620043-SDS-PAGE-1.jpg?v=1771746156","url":"https:\/\/www.ebiohippo.com\/products\/anti-hepatitis-e-virus-hev-porf2-p-domain-neutralizing-antibody-saa2240-bha21405139","provider":"BioHippo","version":"1.0","type":"link"}